SAN DIEGO (AP) _ Pfenex Inc. (PFNX) on Thursday reported a loss of $10.3 million in its second quarter.

The San Diego-based company said it had a loss of 30 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.

The biotechnology company posted revenue of $781,000 in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $2.7 million.

Pfenex shares have decreased 32% since the beginning of the year. The stock has climbed 24% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PFNX at https://www.zacks.com/ap/PFNX

Automated Insights, source Associated Press News